NKT Therapeutics Inc.
Industry: Biotechnology company
DescriptionHeadquarters: Waltham, MA Founded: 2008
NKT Therapeutics Inc. List of Employees There's an exhaustive list of past and present employees! Get comprehensive information on the number of employees at NKT Therapeutics Inc.. You can filter them based on skills, years of employment, job, education, department, and prior employment.
NKT Therapeutics Inc. Salaries. You can even request information on how much does NKT Therapeutics Inc. pay if you want to. Learn about salaries, pros and cons of working for NKT Therapeutics Inc. directly from the past employees.
Find People by Employers You can rekindle an old relationship, reconnect with a long-lost friend, former boss, business acquaintance who might be useful in your new line of work. With our employee database, the possibilities are endless. All you have to do is type in a couple of keywords and we'll bring you the exact information you wanted!
12 NKT Therapeutics Inc. employees in database. Find out everything there's to know about NKT Therapeutics Inc. employees. We offer you a great deal of unbiased information from the internal database, personal records, and many other details that might be of interest to you.
NKT Therapeutics Inc. Employees
Employee
Years
Job
Industry
Nishani Hewage Nishani Hewage's NKT Therapeutics Inc. Experience May 2011 - August 2011
Job Med student at Tufts University School of Medicine
Industry Mental Health Care
Experience
Tufts University School of Medicine Technical Research Assistant, Laboratory of Genetic NeuropharmacologyMcLean HospitalJuly 2012 - July 2014
Tufts University October 2009 - May 2012
Tufts University September 2009 - December 2011
NKT Therapeutics Inc. May 2011 - August 2011
University of Connecticut June 2010 - July 2010
New London Cancer Center July 2008 - September 2009
Lawrence & Memorial Hospital 2007 - 2008
Skills
Microsoft Office, Animal Handling, Filemaker Pro, SPSS, SigmaPlot, PCR, Gel Electrophoresis, Spectrophotometry, ELISA, Ethovision
Education
Tufts University 2008 — 2012
BS, Biopsychology, Spanish
The University of Connecticut 2010 — 2010
Organic Chemistry
Universidad de Alcalá 2010 — 2010
History of Iberoamerica
Tufts University School of Medicine Technical Research Assistant, Laboratory of Genetic NeuropharmacologyMcLean HospitalJuly 2012 - July 2014
Tufts University October 2009 - May 2012
Tufts University September 2009 - December 2011
NKT Therapeutics Inc. May 2011 - August 2011
University of Connecticut June 2010 - July 2010
New London Cancer Center July 2008 - September 2009
Lawrence & Memorial Hospital 2007 - 2008
Skills
Microsoft Office, Animal Handling, Filemaker Pro, SPSS, SigmaPlot, PCR, Gel Electrophoresis, Spectrophotometry, ELISA, Ethovision
Education
Tufts University 2008 — 2012
BS, Biopsychology, Spanish
The University of Connecticut 2010 — 2010
Organic Chemistry
Universidad de Alcalá 2010 — 2010
History of Iberoamerica
Mark Exley Mark Exley's NKT Therapeutics Inc. Experience 2008 - Present
Job Professor at University of Manchester, Assistant Professor at Brigham & Women's Hospital, Harvard Medical School
Industry Hospital & Health Care
Experience
Agenus February 2015 - Present
University of Manchester 2013 - Present
Harvard Medical School, Brigham and Women's Hospital 2012 - Present
NKT Therapeutics Inc. 2008 - Present
Harvard Medical School, Beth Israel Deaconess Med. Ctr. 2002 - 2012
Beth Israel Deaconess Medical Center 1996 - 2002
Immulogic 1992 - 1996
Dana-Farber Cancer Institute 1990 - 1992
Skills
Immunology, Cell Biology, Drug Discovery, Cell, Flow Cytometry, Cancer Immunotherapy, ELISA, Cell Culture, Lifesciences, Drug Development, Cancer, Molecular Biology, Immunochemistry, Virology, Tumor Immunology, Biochemistry, Cancer Research, In Vivo, Assay Development, Translational Research, Immunohistochemistry, Animal Models, Biomarkers, In Vitro, Microscopy, PCR, Oncology, Cell Signaling, Clinical Trials, Infectious Diseases, Biotechnology, Cellular Immunology, Cancer Immunology, Inflammation, Life Sciences
Education
The Institute of Cancer Research, U. of London 1986 — 1989
PhD., Cell Biology / Virology
Kings College London 1984 — 1986
MS, Immunology
Imperial College London 1979 — 1982
BS, Biochemistry
Agenus February 2015 - Present
University of Manchester 2013 - Present
Harvard Medical School, Brigham and Women's Hospital 2012 - Present
NKT Therapeutics Inc. 2008 - Present
Harvard Medical School, Beth Israel Deaconess Med. Ctr. 2002 - 2012
Beth Israel Deaconess Medical Center 1996 - 2002
Immulogic 1992 - 1996
Dana-Farber Cancer Institute 1990 - 1992
Skills
Immunology, Cell Biology, Drug Discovery, Cell, Flow Cytometry, Cancer Immunotherapy, ELISA, Cell Culture, Lifesciences, Drug Development, Cancer, Molecular Biology, Immunochemistry, Virology, Tumor Immunology, Biochemistry, Cancer Research, In Vivo, Assay Development, Translational Research, Immunohistochemistry, Animal Models, Biomarkers, In Vitro, Microscopy, PCR, Oncology, Cell Signaling, Clinical Trials, Infectious Diseases, Biotechnology, Cellular Immunology, Cancer Immunology, Inflammation, Life Sciences
Education
The Institute of Cancer Research, U. of London 1986 — 1989
PhD., Cell Biology / Virology
Kings College London 1984 — 1986
MS, Immunology
Imperial College London 1979 — 1982
BS, Biochemistry
Laura Asinas Blackburn's NKT Therapeutics Inc. Experience February 2012 - Present
Job Independent Regulatory Affairs Consultant
Industry Pharmaceuticals
Experience
NKT Therapeutics Inc. February 2012 - Present
Proteon Therapeutics March 2011 - Present
Inotek Pharmaceuticals November 2009 - Present
Sideris Pharmaceuticals 2013 - 2015
Sideris Pharmaceuticals 2013 - 2015
Infinity Pharmaceuticals May 2012 - January 2014
Foldrx Pharmaceuticals, a wholly owned subsidiary of Pfizer November 2008 - May 2011
Elixir Pharmaceuticals April 2009 - October 2009
Sepracor 2008 - 2009
FoldRx Pharmaceuticals, Inc. May 2006 - October 2008
Skills
Clinical Trials, Clinical Research, Quality Assurance, Management, Regulations, Pharmaceutical Industry, Biotechnology, Clinical Development, Lifesciences, Regulatory Affairs, FDA, Oncology, Regulatory Submissions, GCP, Drug Development, Protocol, IND, CTMS, 21 CFR Part 11, Biopharmaceuticals, Sop, CRO, Validation, EDC, GMP, Pharmacovigilance, Life Sciences
Education
Mount Holyoke College
None, Psychology
Wellesley College
BA, Psychology
Western New England College School of Law
JD, Law
NKT Therapeutics Inc. February 2012 - Present
Proteon Therapeutics March 2011 - Present
Inotek Pharmaceuticals November 2009 - Present
Sideris Pharmaceuticals 2013 - 2015
Sideris Pharmaceuticals 2013 - 2015
Infinity Pharmaceuticals May 2012 - January 2014
Foldrx Pharmaceuticals, a wholly owned subsidiary of Pfizer November 2008 - May 2011
Elixir Pharmaceuticals April 2009 - October 2009
Sepracor 2008 - 2009
FoldRx Pharmaceuticals, Inc. May 2006 - October 2008
Skills
Clinical Trials, Clinical Research, Quality Assurance, Management, Regulations, Pharmaceutical Industry, Biotechnology, Clinical Development, Lifesciences, Regulatory Affairs, FDA, Oncology, Regulatory Submissions, GCP, Drug Development, Protocol, IND, CTMS, 21 CFR Part 11, Biopharmaceuticals, Sop, CRO, Validation, EDC, GMP, Pharmacovigilance, Life Sciences
Education
Mount Holyoke College
None, Psychology
Wellesley College
BA, Psychology
Western New England College School of Law
JD, Law
Ed Mascioli Ed Mascioli's NKT Therapeutics Inc. Experience 2014 - Present
Job Senior Healthcare Executive
Industry Pharmaceuticals
Experience
SV Life Sciences 2014 - Present
NKT Therapeutics Inc. 2014 - Present
Affinium Pharmaceuticals 2013 - 2014
Pfizer 2010 - 2012
Dapis Capital 2008 - 2010
Peptimmune 2007 - 2010
MPM Capital 2001 - 2008
PAREXEL 1997 - 2001
Boston Center of Nutrition 1995 - 1997
Beth Israel Deaconess Medical Center 1990 - 1997
Skills
Entrepreneur, Investments, Healthcare, Life Sciences, Private Equity/Venture..., Corporate Finance, Corporate Governance, Business Strategy, Entrepreneurship, CEOs, Corporate Strategy, Clinical Research, Research and Development, Lifesciences, Biotechnology, Venture Capital, Drug Discovery, Vaccines, Clinical Development, Pharmaceutical Industry, FDA, Private Equity, Drug Development, Commercialization, Clinical Trials, Technology Transfer, Oncology, Medicine, Medical Devices, IND, Biopharmaceuticals, Regulatory Affairs, Infectious Diseases, Biochemistry, Cancer, Genomics, CRO, Licensing, Genetics, Biologics, Corporate Development, Informatics, CTMS, Molecular Biology, R&D, Immunology, Start-ups, Strategy, Management, Due Diligence
Education
Massachusetts Institute of Technology
M.S., Metabolism/Nutrition
Beth Israel Deaconess Medical Center
Internal Medicine Residency
University of Massachusetts Medical School
Doctor of Medicine (M.D.), Internal Medicine
Brandeis University
Bachelor of Arts (B.A.), Biology, General
SV Life Sciences 2014 - Present
NKT Therapeutics Inc. 2014 - Present
Affinium Pharmaceuticals 2013 - 2014
Pfizer 2010 - 2012
Dapis Capital 2008 - 2010
Peptimmune 2007 - 2010
MPM Capital 2001 - 2008
PAREXEL 1997 - 2001
Boston Center of Nutrition 1995 - 1997
Beth Israel Deaconess Medical Center 1990 - 1997
Skills
Entrepreneur, Investments, Healthcare, Life Sciences, Private Equity/Venture..., Corporate Finance, Corporate Governance, Business Strategy, Entrepreneurship, CEOs, Corporate Strategy, Clinical Research, Research and Development, Lifesciences, Biotechnology, Venture Capital, Drug Discovery, Vaccines, Clinical Development, Pharmaceutical Industry, FDA, Private Equity, Drug Development, Commercialization, Clinical Trials, Technology Transfer, Oncology, Medicine, Medical Devices, IND, Biopharmaceuticals, Regulatory Affairs, Infectious Diseases, Biochemistry, Cancer, Genomics, CRO, Licensing, Genetics, Biologics, Corporate Development, Informatics, CTMS, Molecular Biology, R&D, Immunology, Start-ups, Strategy, Management, Due Diligence
Education
Massachusetts Institute of Technology
M.S., Metabolism/Nutrition
Beth Israel Deaconess Medical Center
Internal Medicine Residency
University of Massachusetts Medical School
Doctor of Medicine (M.D.), Internal Medicine
Brandeis University
Bachelor of Arts (B.A.), Biology, General
Felix Scheuplein's NKT Therapeutics Inc. Experience June 2012 - May 2015
Job Associate Director, Translational & Clinical Sciences at Enumeral Biomedical
Industry Biotechnology
Experience
Enumeral Biomedical Holdings, Inc. June 2015 - Present
NKT Therapeutics Inc. June 2012 - May 2015
NKT Therapeutics Inc. September 2009 - June 2012
The Jackson Laboratory April 2006 - August 2009
Institute of Immunology, University of Hamburg, Germany April 2002 - March 2006
Department of Human Genetics, University Medical Center, Hamburg-Eppendorf March 2001 - December 2001
Skills
Immunology, Cell, Monoclonal Antibodies, In Vitro, Flow Cytometry, Clinical Development, Drug Discovery, Biomarkers, Molecular Biology, Drug Development, In Vivo, Cell Based Assays, Animal Models, Assay Development, Project Management, Cell Biology, Oncology, IND, Small Molecules
Education
University of Hamburg 2002 — 2006
PhD, Immunology
University of Hamburg 1995 — 2002
Dipl. Biol., Genetics, Microbiology, Informatics
JAX annual short course mouse models in cancer research
Massbio - Project management class
Enumeral Biomedical Holdings, Inc. June 2015 - Present
NKT Therapeutics Inc. June 2012 - May 2015
NKT Therapeutics Inc. September 2009 - June 2012
The Jackson Laboratory April 2006 - August 2009
Institute of Immunology, University of Hamburg, Germany April 2002 - March 2006
Department of Human Genetics, University Medical Center, Hamburg-Eppendorf March 2001 - December 2001
Skills
Immunology, Cell, Monoclonal Antibodies, In Vitro, Flow Cytometry, Clinical Development, Drug Discovery, Biomarkers, Molecular Biology, Drug Development, In Vivo, Cell Based Assays, Animal Models, Assay Development, Project Management, Cell Biology, Oncology, IND, Small Molecules
Education
University of Hamburg 2002 — 2006
PhD, Immunology
University of Hamburg 1995 — 2002
Dipl. Biol., Genetics, Microbiology, Informatics
JAX annual short course mouse models in cancer research
Massbio - Project management class
Ravi Kirtane's NKT Therapeutics Inc. Experience June 2012 - August 2012
Job Senior Consultant Healthcare at Cognizant Technology Solutions
Industry Management Consulting
Experience
Cognizant Technology Solutions September 2014 - Present
Beacon Health Strategies June 2013 - September 2014
NKT Therapeutics Inc. June 2012 - August 2012
Warnaco June 2009 - June 2011
Mallory & Church, LLC November 2007 - September 2010
Joseph Abboud January 2007 - October 2007
Cowan Financial Group 2006 - 2006
Skills
Financial Analysis, Financial Modeling, Operating Budgets, Financial Projection, Microsoft Office, Forecasting, Hyperion Enterprise, Analysis, Finance, Business Development, Project Management, Retail, Product Management, Budgets, Sales, Valuation
Education
Boston University Graduate School of Management 2011 — 2013
MS-MBA, Health Sector Management
Boston University - School of Management 2002 — 2006
BSBA, Finance
Cognizant Technology Solutions September 2014 - Present
Beacon Health Strategies June 2013 - September 2014
NKT Therapeutics Inc. June 2012 - August 2012
Warnaco June 2009 - June 2011
Mallory & Church, LLC November 2007 - September 2010
Joseph Abboud January 2007 - October 2007
Cowan Financial Group 2006 - 2006
Skills
Financial Analysis, Financial Modeling, Operating Budgets, Financial Projection, Microsoft Office, Forecasting, Hyperion Enterprise, Analysis, Finance, Business Development, Project Management, Retail, Product Management, Budgets, Sales, Valuation
Education
Boston University Graduate School of Management 2011 — 2013
MS-MBA, Health Sector Management
Boston University - School of Management 2002 — 2006
BSBA, Finance
Mark Tepper, Ph.D.'s NKT Therapeutics Inc. Experience August 2007 - August 2008
Job President & Chief Scientific Officer at Corbus Pharmaceuticals
Industry Biotechnology
Experience
Corbus Pharmaceuticals Inc. (fka JB Therapeutics) February 2009 - Present
Mass Medical Angels 2009 - June 2013
Karyon Therapeutics November 2009 - December 2011
NKT Therapeutics Inc. August 2007 - August 2008
RXi Pharmaceuticals (fka Araios Inc.) September 2003 - September 2007
EMD Serono 1995 - 2002
Bristol Myers Squibb 1988 - 1995
Skills
New Business Development, Drug Development, Licensing, Due Diligence, Business Development, R&D, Drug Discovery, Valuation, Strategic Planning, Fundraising, Project Planning, Expert Witness, Biotechnology, Pharmaceutical Industry, Informatics, Oncology, Immunology, Commercialization, Venture Capital, Technology Transfer, Entrepreneurship, Start-ups, Lifesciences
Education
University of Massachusetts Medical School 1985 — 1988
Postdoctoral Fellow
Columbia University College of Physicians and Surgeons 1980 — 1985
Ph.D., M.Phil, MA
Clark University 1976 — 1979
BA
Jonathan Dayton HS
Corbus Pharmaceuticals Inc. (fka JB Therapeutics) February 2009 - Present
Mass Medical Angels 2009 - June 2013
Karyon Therapeutics November 2009 - December 2011
NKT Therapeutics Inc. August 2007 - August 2008
RXi Pharmaceuticals (fka Araios Inc.) September 2003 - September 2007
EMD Serono 1995 - 2002
Bristol Myers Squibb 1988 - 1995
Skills
New Business Development, Drug Development, Licensing, Due Diligence, Business Development, R&D, Drug Discovery, Valuation, Strategic Planning, Fundraising, Project Planning, Expert Witness, Biotechnology, Pharmaceutical Industry, Informatics, Oncology, Immunology, Commercialization, Venture Capital, Technology Transfer, Entrepreneurship, Start-ups, Lifesciences
Education
University of Massachusetts Medical School 1985 — 1988
Postdoctoral Fellow
Columbia University College of Physicians and Surgeons 1980 — 1985
Ph.D., M.Phil, MA
Clark University 1976 — 1979
BA
Jonathan Dayton HS
Barbara Finck's NKT Therapeutics Inc. Experience September 2010 - July 2012
Job Chief Medical Officer
Industry Pharmaceuticals
Experience
Coherus Biosciences July 2012 - Present
NKT Therapeutics Inc. September 2010 - July 2012
Northern California Arthritis Foundation 2012 - 2012
Osprey Pharmaceuticals July 2007 - June 2010
Osprey Pharmaceuticals USA 2007 - June 2010
PDL BioPharma, Inc. 2003 - 2007
Protein Design Labs 2003 - 2007
Protein Design Labs (now PDL BioPharma) 2003 - 2007
Eos Biotechnology 2001 - 2003
Immunex 1996 - 2001
Skills
Biotechnology, Clinical Development, Clinical Trials, Pharmaceutical Industry, Lifesciences, Protein Chemistry
Education
University of California, San Francisco - School of Medicine 1982 — 1986
MD, Internal Medicine and Rheumatology
Coherus Biosciences July 2012 - Present
NKT Therapeutics Inc. September 2010 - July 2012
Northern California Arthritis Foundation 2012 - 2012
Osprey Pharmaceuticals July 2007 - June 2010
Osprey Pharmaceuticals USA 2007 - June 2010
PDL BioPharma, Inc. 2003 - 2007
Protein Design Labs 2003 - 2007
Protein Design Labs (now PDL BioPharma) 2003 - 2007
Eos Biotechnology 2001 - 2003
Immunex 1996 - 2001
Skills
Biotechnology, Clinical Development, Clinical Trials, Pharmaceutical Industry, Lifesciences, Protein Chemistry
Education
University of California, San Francisco - School of Medicine 1982 — 1986
MD, Internal Medicine and Rheumatology
Barbara Finck's NKT Therapeutics Inc. Experience September 2010 - Present
Job at NKT Therapeutics Inc.
Industry Biotechnology
Experience
NKT Therapeutics Inc. September 2010 - Present
Osprey Pharmaceuticals July 2007 - June 2010
PDL BioPharma Inc. 2003 - 2007
Protein Design Labs (now PDL BioPharma) 2003 - 2007
Immunex 1996 - 2001
Immunex (Amgen) 1996 - 2001
Education
University of California, San Francisco - School of Medicine 1982 — 1986
NKT Therapeutics Inc. September 2010 - Present
Osprey Pharmaceuticals July 2007 - June 2010
PDL BioPharma Inc. 2003 - 2007
Protein Design Labs (now PDL BioPharma) 2003 - 2007
Immunex 1996 - 2001
Immunex (Amgen) 1996 - 2001
Education
University of California, San Francisco - School of Medicine 1982 — 1986
Robert Schaub's NKT Therapeutics Inc. Experience December 2011 - Present
Job Chief Science Officer at NKT Therapeutics Inc.
Industry Biotechnology
Experience
NKT Therapeutics Inc. December 2011 - Present
Hematology and Preclinical R&D June 2011 - November 2011
Archemix September 2009 - June 2011
Archemix August 2006 - September 2009
Genetics Institute/Wyeth Research February 1990 - August 2006
Upjohn Company December 1981 - February 1990
University of Tennessee April 1977 - November 1981
Education
Temple University School of Medicine 1975 — 1977
Postdoc, NIH Postdoctoral Fellowship
Washington State University 1973 — 1975
Postdoc, Heart Association Postdoctoral Fellowship
Washington State University 1970 — 1973
Ph.D., Physiology
University of Nevada-Las Vegas 1966 — 1970
B.S., Biology/Chemistry
NKT Therapeutics Inc. December 2011 - Present
Hematology and Preclinical R&D June 2011 - November 2011
Archemix September 2009 - June 2011
Archemix August 2006 - September 2009
Genetics Institute/Wyeth Research February 1990 - August 2006
Upjohn Company December 1981 - February 1990
University of Tennessee April 1977 - November 1981
Education
Temple University School of Medicine 1975 — 1977
Postdoc, NIH Postdoctoral Fellowship
Washington State University 1973 — 1975
Postdoc, Heart Association Postdoctoral Fellowship
Washington State University 1970 — 1973
Ph.D., Physiology
University of Nevada-Las Vegas 1966 — 1970
B.S., Biology/Chemistry
Katherine Schlieper's NKT Therapeutics Inc. Experience November 2010 - December 2011
Job Student at New England College of Optometry
Industry Medical Practice
Experience
New England College of Optometry Research TechnologistMassachusetts Institute of Technology
NKT Therapeutics Inc. November 2010 - December 2011
Education
New England College of Optometry 2013 — 2017
University of Maine at Farmington 2001 — 2004
Bachelor of Arts (BA), Biology, General
New England College of Optometry Research TechnologistMassachusetts Institute of Technology
NKT Therapeutics Inc. November 2010 - December 2011
Education
New England College of Optometry 2013 — 2017
University of Maine at Farmington 2001 — 2004
Bachelor of Arts (BA), Biology, General
Amgen
Biogen Idec
Gilead Sciences
Celgene
Biogen
Amgen Inc
bioMerieux
Centocor